Patients Living Longer With Metastatic Colorectal Cancer

John L. Marshall; Robin Sommers

首页> 外文期刊>Journal of the advanced practitioner in oncology >Patients Living Longer With Metastatic Colorectal Cancer

【24h】

Patients Living Longer With Metastatic Colorectal Cancer

机译：

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Advances in the treatment of metastatic colorectal cancer have greatly improved survival for these patients, and novel approaches on the horizon are particularly exciting, according to John L. Marshall, MD, of Georgetown Lombardi Cancer Center in Washington, DC, who described the treatment landscape for this malignancy at 2015 JADPRO LiveatAPSHO. Colorectal cancer (CRC) is now being recognized as not just one disease, but a cancer with a number of molecular subtypes. It is classified as microsatellite stable (MSS) or unstable (MSI) and as RAS wild-type or mutant; then it is classified anatomically by colon vs. rectum and right side vs. left side of the colon. Most recently, gene profiles and stool flora types are being explored, and researchers are studying how the environment (particularly foods) interacts with the mi-croflora to affect CRC risk.

著录项

来源
《Journal of the advanced practitioner in oncology》 |2016年第3期|286-288|共3页
作者
John L. Marshall; Robin Sommers;
展开▼
作者单位

Georgetown Lombardi Cancer Center in Washington, DC, and Dana-Farber Cancer Institute, Boston;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: Focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne/Pays de la Loire) [J] . MetgesJ.P., LebotM.A., FarouxR.RiaudF.GamelinE.CapitainO.GuérinMeyerV.LeyniaP.DouillardJ.Y.SenellartH.RochardS.LouvignéC.CampionL.DupuisO.GrollierC.AchourN.A.PersonB.RaoulJ.L.BoucherE.BertrandC.RaméeJ.F.GuivarchL.EtienneP.L.RousselS.DesclosH.JulienM.N.LabarreM.I.KleinV.BessardR.StampfliC.RoyetF.FaycalJ.GouvaS.LeBihanG.CouturierM.GourlaouenA.BertholomC.PorneufM.JobardE.PeguetE.GrassetD.BouretJ.F.BichelerV.UlvoasA.MiglianicoL.ChouzenouxC.DeguiralP.DerenneL.MartinD.LangletP.M.BodinC.RossiV.BarréS.CojocarasuO.NaveauPlouxC.VidalA.M.CuminI.EgreteauJ.BrouardA.MatysiakBudnikT.ThomaréP.LeBrisMichelA.S.PiriouG.LargeauR.ElhannaniC.CrespeauE.SubervilleF.BourgeoisH.RicheC.LagadecD.D.MarhuendaF.GrudéF. Oncologie . 2014,第5期

机译：Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: Focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne/Pays de la Loire)
2. Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): Individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group [J] . GiessenC., GraevenU., LaubenderR.P.ModestD.P.SchulzC.PorschenR.SchmiegelW.Reinacher-SchickA.Hegewisch-BeckerS.StintzingS.HeinemannV. Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第12期

机译：Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): Individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group
3. Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France [J] . MontserratRoset, MayurAmonkar, RennaPatelNúriaLaraSmitaKothari Advances in therapy. . 2022,第3期

机译：Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France
4. Adequate Selection of Fluoropyrimidines for Colorectal Cancer [C] . H. Usuki, S. Akamoto, T. Sugiyama, Asian Federation of Coloproctology . 2005

机译：Adequate Selection of Fluoropyrimidines for Colorectal Cancer
5. Living Bodhisattvas— Historical and Textual Sources of Practitioner Identity in the Tzu Chi School of Buddhism [D] . Freese, Allen Courtland. 2019

机译：Living Bodhisattvas-佛教学派学派的历史和文本来源
6. Retraction statement: ‘Formin‐like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer’ by Yuanfeng Zeng Huijun Xie Yudan Qiao Jianmei Wang Xiling Zhu Guoyang He Yuling Li Xiaoli Ren Feifei Wang Li Liang and Yanqing Ding [O] . 2016

机译：Retraction statement: ‘Formin‐like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer’ by Yuanfeng Zeng Huijun Xie Yudan Qiao Jianmei Wang Xiling Zhu Guoyang He Yuling Li Xiaoli Ren Feifei Wang Li Liang and Yanqing Ding
7. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy [O] . Sun Weijing 2012

机译：angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
8. Tratamiento para el Cancer de Prostata: Guia para Hombres con Cancer Localizado de Prostata (Treating Prostate Cancer: A Guide for Men with Localized Prostate Cancer). [R] . 2008

机译：Tratamiento para el Cancer de prostata：Guia para Hombres con Cancer Localizado de prostata（治疗前列腺癌：患有局部前列腺癌的男性指南）。

Patients Living Longer With Metastatic Colorectal Cancer

摘要

著录项

相似文献

相关主题

期刊订阅